“The Next Big Things” in Cardiovascular Medicine
Valentin Fuster, MD, PhD, hosts the American College of Cardiology’s 47th New York Cardiovascular Symposium.
More than 2,000 experts in the field of cardiovascular medicine will attend the annual American College of Cardiology 47th New York Cardiovascular Symposium December 12-14 at the New York Hilton-Midtown, which will highlight "The Next Big Things" in cardiovascular medicine.
For the 21st consecutive year, Valentin Fuster, MD, PhD, MACC, will direct the three-day cardiology course with expert lectures and panel debates by more than 50 leading, international cardiovascular specialists.
"Our Symposium brings together for you the world's leading cardiovascular medicine experts to review 2014's latest scientific advancements and cutting-edge technologies for treating cardiovascular disease," says Dr. Valentin Fuster, Director of Mount Sinai Heart, and Physician-in-Chief of The Mount Sinai Hospital.
"This once a year cutting-edge course may have the most positive impact on your practice and most importantly, your patients, while revealing the next big breakthroughs to come in 2015 and beyond for the field of cardiology," says Dr. Fuster, a global leader in cardiovascular medicine and the Editor-in-Chief of the Journal of the American College of Cardiology (JACC).
A major highlight of the Symposium will be the special presentations of "The Next Big Things" in cardiovascular medicine including:
•Coronary Artery Bypass Graft (CABG) for Complex Coronary Disease in the Diabetic and in the Elderly.
•The Polypill for Secondary Prevention is Entering the Cardiovascular Field.
•The Impact of Cardiovascular Risk Factors in Degenerative Brain Disease and Aging.
•The Result of Advances in Imaging and Cognitive Function Testing.
The Symposium, a partnership between the American College of Cardiology and The New York Cardiological Society, will begin on Dec. 12 with speeches by: Shalom Jacobovitz , Chief Executive Officer, American College of Cardiology; Patrick T. O'Gara, MD, FACC, President, American College of Cardiology; and Smadar Kort, MD, FACC, Governor, American College of Cardiology, Downstate New York.
The audience of cardiologists, cardiac interventionalists, electrophysiologists, cardiac surgeons, nurses, and other healthcare professionals will learn about the latest, research, technological, and therapeutic advancements of 2014 and challenges for 2015. The event's expert lectures and discussions will span across advances in the field of cardiovascular medicine about prevention of heart disease and stroke, coronary artery disease, arrhythmias, heart attack, heart failure, heart surgery, cardiac imaging, aortic and valvular heart disease, genetics, gene therapy, and cell regeneration.
The full agenda for the American College of Cardiology 47th New York Cardiovascular Symposium is available, here.
About the Mount Sinai Health System
Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. Its comprehensive system includes seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, the Icahn School of Medicine at Mount Sinai, the Graduate School of Biomedical Sciences, and the Mount Sinai Phillips School of Nursing. Together, the Health System comprises approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses.
As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.
Mount Sinai is consistently recognized among the nation’s leading academic health systems for patient care, research, and education. The Mount Sinai Hospital is ranked No. 1 in New York by Newsweek and No. 5 on the magazine’s World’s Best Hospitals list. The Icahn School of Medicine at Mount Sinai ranks No. 11 among U.S. medical schools and No. 1 among freestanding medical schools for National Institutes of Health funding, reflecting the strength of its scientific enterprise and leadership in biomedical research.
Mount Sinai Scientists Uncover Link Between Influenza and Heart Disease
Feb 09, 2026 View All Press Releases
Scientists Develop a Smarter mRNA Therapy That Knows Which Cells to Target
Dec 15, 2025 View All Press Releases